Elliot Norry serves as Executive at Adaptimmune Therapeutics PLC, where they oversee executive responsibilities. Since joining the company, Elliot Norry has executed 17 insider transactions totaling $102.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 17, 2024 involved selling 12,967 shares valued at $8.7K.
Elliot Norry currently holds 19,257 shares of Adaptimmune Therapeutics PLC (ADAP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Elliot Norry has been a net seller of ADAP stock. They have purchased $0 and sold $102.0K worth of shares.
Elliot Norry's most recent insider trade was on Jan 17, 2024, when they sold 12,967 shares at $0.67 per share.
Get notified when new Form 4 filings are submitted
| $0.67 |
| Discretionary |
| Jan 16, 2024 | ADAP | $1.8K | Sale | 2,287 | $0.79 | Discretionary |
| Jan 12, 2024 | ADAP | $6.6K | Sale | 7,799 | $0.85 | Discretionary |
| Jan 11, 2024 | ADAP | $3.4K | Sale | 4,009 | $0.84 | Discretionary |
| Jan 17, 2023 | ADAP | $4.0K | Sale | 2,159 | $1.86 | Discretionary |
| Jan 12, 2023 | ADAP | $12.7K | Sale | 7,449 | $1.71 | Discretionary |
| Jan 11, 2023 | ADAP | $6.7K | Sale | 3,843 | $1.75 | Discretionary |
| Jan 4, 2023 | ADAP | $1.5K | Sale | 876 | $1.69 | Discretionary |
| Jan 18, 2022 | ADAP | $6.8K | Sale | 2,121 | $3.19 | Discretionary |
| Jan 12, 2022 | ADAP | $3.0K | Sale | 854 | $3.54 | Discretionary |
| Jan 11, 2022 | ADAP | $13.4K | Sale | 3,770 | $3.56 | Discretionary |
| Jan 4, 2022 | ADAP | $3.4K | Sale | 849 | $4.06 | Discretionary |
| Jan 19, 2021 | ADAP | $12.0K | Sale | 2,111 | $5.67 | Discretionary |
| Jan 12, 2021 | ADAP | $5.2K | Sale | 841 | $6.15 | Discretionary |
| Jan 4, 2021 | ADAP | $4.5K | Sale | 845 | $5.33 | Discretionary |
| Jan 14, 2020 | ADAP | $4.7K | Sale | 911 | $5.13 | Discretionary |